Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 163, Issue -, Pages 333-343Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.11.047
Keywords
Isoquinoline; Gold(III) complexes; Cell apoptosis; Mitochondrial dysfunction; Antitumor activity
Categories
Funding
- National Natural Science Foundation of China [81473102, 21431001, IRT_16R15]
- Natural Science Foundation of Guangxi Province of China [2016GXNSFGA380005]
- BAGUI Scholar program of Guangxi Province of China
Ask authors/readers for more resources
Two gold(III) complexes of isoquinoline derivatives: [Au(L-1)Cl-2] (Au1) and [Au(L-2)Cl-2] (Au2) have been prepared and characterized. Aul and Au2 exhibited greater cytotoxicity than their corresponding ligands and cisplatin against T-24 cells. Both complexes arrested cell cycle at S-phase by upregulation of p53, p27, and p21, and downregulation of cyclin A and cyclin E. The depolarization of the mitochondrial membrane potential, generation of ROS, and stimulated Ca2+ release activated the caspase cascade and ultimately caused apoptosis by increasing the levels of Bax and Bak, and decreasing the levels of Bcl-2 and Bcl-xl. Cell apoptosis was achieved via mitochondria mediated pathways. The in vivo studies of Au1 and Au2 demonstrated that they were safer than cisplatin and could effectively inhibit tumor growth. (C) 2018 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available